Skip to content

Homeopathic treatment of painful menses

Double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines in improving pain of primary dysmenorrhoea in women of reproductive age group

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050190
Enrollment
81
Registered
2023-03-01
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
dosage and repetition will be maintained depending upon the individual requirement of the cases. All sundry items will be procured from a Good Manufacturing Practice (GMP

Sponsors

D N De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Female patients age between 12 years to 45 years. 2. Patients suffering from PD, pain score of 4-9 on NRS. (ICD-10 code N94.4) 3. Menstrual pain that hampers the day to activity of life. 4. Patients having menstrual pain which may radiate to back or thigh. 5. Female willing to provide a written informed consent voluntarily; illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires

Exclusion criteria

Exclusion criteria: 1.Patients having any abnormal pelvic pathology in ultrasonography of lower abdomen. 2.Patients undergoing any hormone replacement therapy, using contraceptive pills or history of their use in previous 3months. 3.Patients on NSAIDs therapy for dysmenorrhoea in regular basis. 4.Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life and vulnerable population like unconscious, too sick for consultation, differently abled etc. 5.Patient under tobacco chewing and/or smoking, alcoholism and/or any other from(s) of substance abuse and/or dependence. 6.Self-reported immune-compromised state. 7.Patients already undergoing homoeopathic or other system treatment with in last six months. 8.Simultaneous participation in any other clinical trials

Design outcomes

Primary

MeasureTime frame
0-10 numeric rating scale measuring intensity of painTimepoint: Day 1 and day 2 of menstruation for 3 consecutive months

Secondary

MeasureTime frame
Dysmenorrhoea Symptom Interference Scale (DSI)Timepoint: Every month, up to 3 months;Frequency of taking PCM or NSAIDs as rescue remediesTimepoint: Every month, up to 3 months;Measure yourself medical outcome profile 2 (MYMOP-2)Timepoint: Every month, up to 3 months

Countries

India

Contacts

Public ContactSaima Shamim

D N De Homoeopathic Medical College and Hospital

drsaima_7@yahoo.com7059526218

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026